The Cancer Research Institute is currently accepting applications for the CRI Irvington Postdoctoral Fellowship Program.(https://give.cancerresearch.org/site/R?i=iAKUqNCkNGfYS-QFzkP3GQ) This program furthers career development and supports laboratory research for promising young scientists working under the mentorship of leading immunologists.
In recent years, significant advances in immunotherapy have yielded major breakthroughs in cancer treatment. CRI recognizes, however, that getting to the next great breakthrough will require continued investment in fundamental research and training. With this in mind, CRI invites postdoctoral fellows to apply for funding to support hypothesis-driven, mechanistic studies in both basic immunology and tumor immunology that aim to directly impact our understanding of the immune system’s role in cancer.
An Additional Opportunity
Thanks to a collaboration with the Fibrolamellar Cancer Foundation, CRI has secured limited funding for additional postdoctoral fellowships for candidates whose projects are focused on understanding the immunological response to fibrolamellar carcinoma and accelerating the development of effective immunotherapy treatments for this rare, aggressive liver cancer that occurs predominantly in otherwise healthy adolescents and young adults.
Applicants should submit to the general CRI Irvington Postdoctoral Fellowship Program and any application in this area will be considered eligible for this special funding opportunity. This opportunity is in addition to our standard call for applications.
Funding: $175,500 over three years
Sponsor Deadline: April 1, 2021. Proposals is due in OSRP by March 25, 2021. For questions, contact firstname.lastname@example.org.